Choice should be based on patient ability to tolerate and use inhaler device.
The material on this site is subject to copyright protection of the Derbyshire CCGs unless otherwise indicated.
Spiolto Respimat contains the active ingredients tiotropium and olodaterol, at a strength of 2.5/2.5 micrograms respectively, per dose. It is licensed as a maintenance bronchodilator treatment to relieve symptoms in adults with COPD. Tiotropium patrí do podskupiny anticholínergík, olodaterol patrí do podskupiny dlhodobo pôsobiacich beta2 agonistov.
Stiolto Respimat (olodaterol/tiotropium) is a member of the bronchodilator combinations drug class and is commonly used for COPD and COPD - Maintenance. Available for Android and iOS devices. A Respimat is used with a number of different medications. endstream endobj 1121 0 obj <
Los mayores efectos broncodilatadores observados con SPIOLTO RESPIMAT ® en comparación con tiotropio 5 microgramos y olodaterol 5 microgramos se mantuvieron a lo largo de todo el periodo de tratamiento de 52 semanas. Spiolto Respimat 2.5micrograms/dose / 2.5micrograms/dose inhalation solution refill cartridge (Boehringer Ingelheim Ltd)
0 It is not known if Stiolto Respimat is safe and effective in children.Before you use Stiolto Respimat, tell your healthcare provider about all of your medical conditions, including if you:Tell your healthcare provider about all the medicines you take,Read the step-by-step instructions for using Stiolto Respimat at the end of this Patient Information leaflet.Do not use Stiolto Respimat more often than prescribed.Use 1 dose (2 puffs) of Stiolto Respimat, 1 time each day, at the same time of the day.If you take too much Stiolto Respimat, call your healthcare provider or go to the nearest hospital emergency room right away.Stiolto Respimat does not relieve sudden symptoms of COPD. Our website uses cookies. No reproduction by or for commercial organisations, for any purpose is permitted without the express written permission of JAPC.© Derbyshire Medicines Management, Prescribing and GuidelinesSee local COPD guidance. I’m going to show you how to use a You should not take extra doses of Stiolto Respimat to relieve sudden symptoms of COPD.Call your healthcare provider or get emergency medical care right away ifWhat are the possible side effects with Stiolto Respimat?STIOLTO RESPIMAT can cause serious side effects, including:call your healthcare provider if breathing problems worsen over time while using Stiolto Respimat.using too much of a LABA medicine (one of the medicines in Stiolto Respimat) may cause:serious allergic reactions including rash, hives, itching, swelling of the face, lips, tongue, throat, difficulties in breathing or swallowing.sudden shortness of breath can happen immediately after using Stiolto Respimat.new or worsening eye problems including acute narrow-angle glaucoma.changes in laboratory blood levels including high blood sugar (hyperglycemia) and low levels of potassium (hypokalemia), whichKeep your Stiolto Respimat inhaler, cartridge, and all medicines out of the reach of children.General information about the safe and effective use of Stiolto RespimatDo not turn the clear base before inserting the cartridge.Keep your Stiolto Respimat cartridge, inhaler, and all medicines out of the reach of children.After complete preparation of your inhaler, it will be ready to deliver the number of puffs on the label.It is difficult to insert the cartridge deep enough:Did you accidentally turn the clear base before inserting the cartridge?Did you insert the cartridge with the wide end first?Is the dose indicator on the Stiolto Respimat pointing to 0 (zero)?The dose indicator on the Stiolto Respimat reaches 0 (zero) too soon:Did you use Stiolto Respimat as indicated (2 puffs 1 time each day)?Did you turn the clear base before you inserted the cartridge?Did you spray in the air often to check whether the Stiolto Respimat is working?Did you insert the cartridge into a used Stiolto Respimat?Did you press the dose-release button when turning the clear base?Did you stop when turning the clear base before it clicked?Did you repeat Turn, Open, Press (TOP) less than 3 times after inserting the cartridge?Is the dose indicator on the STIOLTO RESPIMAT pointing to 0 (zero)?We comply with the HONcode standard for trustworthy health information -
Excipient with known effect: This medicine … The Stiolto Respimat cartridge is intended only for use with the Stiolto Respimat inhaler.
The All Wales Medicines Strategy Group has advised (December 2018) that tiotropium (Spiriva Respimat ®) is recommended as an option for use within NHS Wales as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.
Popis Spiolto Respimat 2,5 /2,5 mikrogramov sol ihl 1x(1 inh.+1 náplň/60 vstrekov), 1x1 set: Liek obsahuje dva liečivá s názvom tiotropium a olodaterol.
Stiolto Respimat Prices This Stiolto Respimat price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Spiolto ® Respimat ® Maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). Spiolto Respimat inhalation solution contains tiotropium (a LAMA) and olodaterol (a LABA). Stiolto Respimat is not indicated for the treatment of asthma A 28-week, placebo-controlled US study comparing the safety of another LABA (salmeterol) with placebo, each added to usual asthma therapy, showed an increase in asthma-related deaths in patients receiving salmeterol (13/13,176 in patients treated with salmeterol vs. 3/13,179 in patients treated with placebo; RR 4.37, 95% CI 1.25, 15.34). �E �DV@Z���R��f`�^�
1120 0 obj <> endobj %PDF-1.5 %����